ASCO 2025 — Let’s Talk About What’s Next in Oncology

Read article

ASCO 2025 — Let’s Talk About What’s Next in Oncology

Medelis will be attending ASCO 2025 in Chicago…
Read Article

How AI is Transforming New Drug Discovery

Traditional drug discovery is immensely difficult. New drug…
Read Article

Preparing for Your Targeted Treatment in the Clinic

For the VP of Clinical Operations (or a…
Read Article

ASCO 2024 – Takeaways from Five Key Studies

If you didn’t get to attend the 2024…
Read Article

Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024

The 2024 ASCO Annual Meeting presents an unmissable…
Read Article

Embracing AI in Clinical Trials: An Oncology CRO’s Insight

In our previous article, we outlined how AI…
Read Article

Transforming Oncology Drug Development with Artificial Intelligence

The release of GPT 3.5 and the improvement…
Read Article

FDA’s New Guidance on Diversity in Clinical Trials: New Challenges for Patient Recruitment

The U.S. Food and Drug Administration (FDA) recently…
Read Article

The Poster Child of International Clinical Trial Success: Legend Biotech’s Carvykti/Cilta-cel Immunotherapy Achieves FDA Approval

With many in biotech and pharma in China…
Read Article